global projects move genomic medicine to the next level
DESCRIPTION
Genomics England is selecting companies with advanced capabilities to provide clinical interpretation for the 100K Genomes Project. NextCODE Health received top marks for its analytical capabilities across all the categories evaluated: Rare disease interpretation, secondary pipeline analysis, and cancer interpretation.TRANSCRIPT
Global Projects Move Genomic Medicine to the Next Level
Hannes Smarason Genome Sequencing |Personalized Medicine | Transforming Health Care
The Next Level in Genomic Medicine New genomics-‐based technologies and tools are making their way into a range of exci@ng research programs and clinical studies around the world. Leading-‐edge organiza@ons are quickly adop@ng hardware for sequencing and systems for collec@ng genomic data. Now, the focus has turned to analysis and interpreta@on – the cri@cal component necessary to gain the insights from the sequence data that will transform medicine.
Global Projects Employing Sequencing • Earlier this year, Genomics England announced investments
for broad sequencing and analysis of 100,000 human genomes.
• At the @me, Genomics England had selected Illumina as its sequencing partner and was coordina@ng resources and centers to support the effort, including resourcing for analysis and interpreta@on. [See blog post here.]
• Other ini@a@ves, such as the Qatar genomics program and the ini@a@ves by Longevity and Regeneron also represent the accelerated progress in seeking medical advancements from genomic data insights. [See blog post here.]
Genomics England Turns to Data Analysis
• This week, Genomics England announced a select group of companies with advanced capabili@es to move to the next stage of evalua@on to provide clinical interpreta@on for the 100K Genomes Project.
• At the @p top was NextCODE, which received top marks by Genomics England for its analy@cal capabili@es across all the categories evaluated: rare disease interpreta@on, secondary pipeline analysis and cancer interpreta@on.
[See release here.]
NextCODE Technology on Top • The company’s advanced Genomically-‐Ordered Rela@onal
database, or GOR, combined with its clinical and discovery interfaces offer the most advanced and reliable capabili@es to support the ambi@ous tasks undertaken by Genomics England, and are already proven at popula@on scale. [Read more on the GOR database here.]
The coming months will be a very exci@ng @me for genomic medicine, with interpreta@on taking the spotlight as we take leaps toward the next stage of personalized medicine. Read more about NextCODE’s work here.
ExciFng Times Ahead